Speaker illustration

Doctor Matija Cevc

University Medical Centre of Ljubljana, Ljubljana (Slovenia)

Comparison of efficacy and safety of rosuvastatin 15 mg vs. 10 mg: subanalysis of the ROSU-PATH trial

Event: ESC Congress 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Cardiovascular prevention outcomes I

Thumbnail

ESC 365 is supported by

logo Novo Nordisk